Appraisal of chronic low back pain (CLBP) treatment outcome is incomplete unless results can be shown to be stable over an extended follow-up period. This paper concentrates on methods by which the long-term trends of objective outcome assessments can be studied and predictions developed given incomplete data. Employment and litigation status, self-rating of pain, activities, medications, and hospitalizations related to pain were periodically assessed in up to 210 graduates of a CLBP treatment program, over a period of 6 months to 5 years following treatment. Favorable outcomes were achieved by many of the respondents, and a good degree of stability in outcomes was observed in several of the measures. Few indicators were found which adequately predict long-term outcomes, however. Attrition in the sample and other possible systematic sources of bias are discussed.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/0304-3959(87)90175-8 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Dietary and Nutritional Aspects of Metabolic Syndrome Management: An Overview.
Endocr Metab Immune Disord Drug Targets
January 2025
Pharmacy Department, Tishk International University, Erbil, Kurdistan Region, Iraq.
Sedentary lifestyles and prolonged physical inactivity are often linked to poor mental and physical health as well as an increased risk of a number of chronic illnesses, including cancer, obesity, type 2 diabetes, and cardiovascular problems. Metabolic Syndrome (MetS), as the new disease, has emerged as the world's leading cause of illness. Despite having its roots in the West, this issue has now completely globalized due to the development of the Western way of life throughout the world.
View Article and Find Full Text PDFBackground And Objective: Lipedema is a commonly underdiagnosed chronic condition. This study aimed to evaluate liposuction techniques for lipedema by conducting a systematic review and presenting our experience. A case series study and a comprehensive review were conducted.
View Article and Find Full Text PDFUsefulness of polymerase chain reaction tests in Chagas disease studies.
Front Parasitol
February 2024
National Reference Center for Parasitology, Research Institute of the McGill University Center, Montreal, QC, Canada.
The Polymerase Chain Reaction (PCR) test is a highly sensitive, specific, and rapid diagnostic tool for Chagas disease. Chagas disease is caused by the protozoan flagellate and is endemic to the Americas. While conventional serological methods are still used in the diagnosis of Chagas disease, they are being gradually replaced by molecular methods like PCR.
View Article and Find Full Text PDFCurrent source density and functional connectivity extracted from resting-state electroencephalography as biomarkers for chronic low back pain.
Pain Rep
February 2025
Department of Occupational Therapy, Graduate School of Rehabilitation Science, Osaka Metropolitan University, Osaka, Japan.
Introduction: Chronic low back pain (CLBP) is a global health issue, and its nonspecific causes make treatment challenging. Understanding the neural mechanisms of CLBP should contribute to developing effective therapies.
Objectives: To compare current source density (CSD) and functional connectivity (FC) extracted from resting electroencephalography (EEG) between patients with CLBP and healthy controls and to examine the correlations between EEG indices and symptoms.
An end is in sight: a perspective on PCR as an endpoint for Chagas disease treatment trials.
Front Parasitol
October 2023
Novartis Biomedical Research, Cambridge, MA, United States.
Novel therapies for chronic indeterminate Chagas disease (CICD) are needed, but trials are limited by the absence of tests to detect infection and early treatment efficacy. This perspective highlights the shortfalls and strengths of polymerase chain reaction (PCR) as a study endpoint for anti-parasitic drug development. Serologic reversion, the gold standard test of cure, may take decades to occur in adults and therefore is challenging as an endpoint for drug development.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!